Pulse.

a daily field guide to health research that matters

◆ Console

‹ Sun · 25 Oct 2026
Promising but preliminary

The prospects and challenges of the use of cell-free DNA as a diagnostic and prognostic biomarker for oral cancer in Sub-Saharan Africa

Blood-based cancer tests adapted for African settings could help detect oral cancer earlier where delayed diagnosis drives high mortality.

Oral cancer morbidity and mortality are rising in Sub-Saharan Africa due to delayed diagnosis, poor infrastructure, and socioeconomic barriers; this review evaluates cfDNA liquid biopsy as a minimally invasive diagnostic tool applicable to SSA's oral cancer burden. The review identifies the need for population-specific validation, multicentre SSA data panels, and adaptation of existing cfDNA protocols to resource-limited settings.

What the study was

Study design
Narrative review
Category
T3: Early cancer detection
Maturity
Exploratory
Journal
The Journal of Liquid Biopsy

Why it surfaced

Addresses significant unmet need in an underserved population where oral cancer is a growing public health problem; cfDNA liquid biopsy aligns directly with early cancer detection watchlist goals and highlights global equity dimensions of diagnostic innovation.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.